Elliott M. Levy
CIK: 0001858745
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)1 (33.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Levy Elliott M.
Levy Elliott M. (SEC CIK 0001858745) files insider reports with the SEC as Director of NuCana plc (NCNA) and Director of Editas Medicine, Inc. (EDIT).
Signal8 holds 4 ownership filings by Levy Elliott M. (1 Form 3, 3 Form 4), filed between Jun 10, 2025 and Jun 24, 2026. Those filings report 3 transactions, from Jun 6, 2025 to Jun 19, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Levy Elliott M.'s filings is in CAMBRIDGE, MA.
Recent filings by Levy Elliott M.
Other insiders filing for NuCana plc (NCNA)
- Bloss Jeffrey D., Chief Medical Officer
- Bruce Theresa Margaret Ms, Chief Operating Officer
- Harrison David James, Head of Translational Medicine
- Mellish Martin C.B., Director
- Webster Ian Alexander
- Kay Andrew Martin, Director